Cite
HARVARD Citation
Murray, M. et al. (2019). Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study. HIV research & clinical practice. 20 (4), pp. 111-122. [Online].